Isolated hereditary giant platelet disorder

Isolated hereditary giant platelet disorder (also referred to as isolated inherited macrothrombocytopenia) is a rare inherited bleeding disorder characterized by the presence of abnormally large platelets (giant platelets or macrothrombocytes) in the peripheral blood, often accompanied by a reduced platelet count (thrombocytopenia). Unlike syndromic giant platelet disorders such as Bernard-Soulier syndrome or MYH9-related disorders, this condition occurs in isolation without associated systemic features such as kidney disease, hearing loss, or cataracts. The disorder primarily affects the hematologic system. Patients may experience a mild to moderate bleeding tendency, which can manifest as easy bruising, prolonged bleeding from cuts or dental procedures, menorrhagia (heavy menstrual bleeding) in women, and occasionally more significant hemorrhagic episodes following surgery or trauma. The severity of bleeding symptoms varies considerably among affected individuals, and some patients may remain largely asymptomatic despite laboratory abnormalities. Platelet function may be normal or mildly impaired depending on the specific underlying genetic defect. Diagnosis is typically based on the combination of persistent macrothrombocytopenia identified on complete blood count and peripheral blood smear, a family history consistent with hereditary transmission, and the exclusion of other known syndromic platelet disorders and acquired causes of thrombocytopenia. Genetic testing may help identify causative mutations in genes involved in platelet production and megakaryocyte maturation. Treatment is generally supportive and includes avoidance of antiplatelet medications, use of antifibrinolytic agents (such as tranexamic acid) for minor bleeding episodes, and platelet transfusions for severe hemorrhage or prior to major surgical procedures. Most patients have a favorable prognosis with appropriate management.

Common questions about Isolated hereditary giant platelet disorder